)
)
WuXi Biologics Investor Relations Material
Latest events
H1 2024
WuXi Biologics
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from WuXi Biologics (Cayman) Inc
Access all reports
WuXi Biologics (Cayman) Inc. is a global contract research, development, and manufacturing organization (CRDMO) focused on biologics. The company offers comprehensive services that span from biologic discovery and development to commercial manufacturing. Key offerings include protein generation, antibody development, assay development, and regulatory affairs. The company is headquartered in Wuxi, China, and its shares are listed on the Hong Kong Stock Exchange.
Key slides for WuXi Biologics (Cayman) Inc
H1 2024
WuXi Biologics (Cayman) Inc
H1 2024
WuXi Biologics (Cayman) Inc
Latest articles
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
)
Lessons from Gautam Baid: Mastering Simplicity and Compounding
Gautam Baid's journey of compounding wisdom, investing simplicity, and lifelong learning – insights to transform your financial and personal growth.
13 Dec 2024
)
Rocket Lab: Breaking Ground in Space
Rocket Lab has been one of the pioneers in the commercial aerospace industry, with numerous satellite launches and space system applications.
9 Dec 2024
Ticker symbol
2269
Country
🇭🇰 Hong Kong